Articles tagged with Cancer Patients
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A study found that elderly COPD patients who use inhaled steroids can significantly reduce their rehospitalization and death risk. Additionally, postmenopausal women are more likely to develop sleep apnea and have a severe form of the condition. Meanwhile, researchers discovered age bias in lung cancer treatment, with older patients be...
A study of 31 prostate cancer patients found that quality of life returns to normal within a year following brachytherapy, with urinary symptoms disappearing. The treatment was compared to other options like removal of the prostate or standard radiation therapy, which carry higher risks of decreased sexual function and bowel problems.
A new software program developed by Emory researchers uses data from 840 previous patients to predict outcomes in new patients. The genetic adaptive model has an accuracy rate of 76 percent and can help determine a patient's chances of cancer recurrence after treatment, guiding doctors towards the best treatment option.
A new study by University of North Carolina at Chapel Hill researchers shows a simple breath test can distinguish between patients who metabolize chemotherapy drugs normally and those who require lower doses for safety. The technique, which measures exhaled carbon dioxide, has promising advantages in reducing toxicity in patients.
A study of 42 breast cancer patients found that those who chose experimental treatments had higher levels of psychological distress, despite similar physical abilities. Researchers suggest that these women may feel a greater need to feel in control and desperate for effective treatment options.
Researchers at the University of Pennsylvania Cancer Center have successfully conducted a Phase I clinical trial on combretastatin A4 phosphate, a vascular targeting agent. The study found that patients with solid tumors were able to safely tolerate the treatment and showed evidence of decreased blood flow to the tumor.
OHSU researchers successfully delivered chemotherapy across the blood-brain barrier for patients with primary central nervous system lymphomas. The study showed that 93% of treated patients achieved a complete response and participating centers outperformed OHSU in blood-brain barrier disruptions.
A review paper by University of Pittsburgh researcher James J. Dignam suggests that physiological responses to treatments are not responsible for poorer outcomes among blacks. Black women with the same stage of breast cancer have more advanced disease conditions due to less access to or utilization of healthcare resources.
Researchers at the Mayo Clinic found that an experimental diode laser treatment controlled cancer growth in all but one patient with melanoma in the eye. No recurrences were noted in the remaining patients during follow-up periods.
A study published in Neurosurgery found that 42% of patients survived five years or more after receiving enhanced chemotherapy through blood-brain barrier disruption. The treatment also showed no cognitive loss or impairment in 36 patients, contrary to previous studies.
A new treatment approach combining traditional chemotherapy with medication delivered through an implanted pump has been found to significantly increase two-year survival rates and decrease tumor recurrence in patients with advanced colorectal cancer that has spread to the liver. The study, published in the New England Journal of Medic...
A study of over 6,000 patients found that one in every 100 people misdiagnosed due to a single pathologist's report. This can lead to incorrect treatment, surgery, or chemotherapy, causing psychological trauma and financial burden.
Researchers are examining whether high doses of vitamin D can stop the progression or destroy prostate cancer. If successful, patients may be able to delay aggressive treatment and stay on the treatment indefinitely.
Lung cancer treatment disparities between blacks and whites are attributed to racial attitudes and biases, affecting surgical resection rates and survival outcomes. UCSF specialists emphasize the importance of addressing these inequities through improved communication, screening tests, and clinical trials.
Researchers found that patients who previously received hormone therapy with tamoxifen, had no prior chemotherapy, and had limited metastases were more likely to live longer after high-dose chemotherapy with transplant. This study suggests that closely monitoring high-risk patients can improve treatment outcomes.
A nursing intervention program involving weekly telephone calls with nurses improves cancer patients' ability to manage symptoms, communicate concerns, and advocate for their own care. The program also benefits family caregivers, reducing time spent on managing side effects and improving quality of life.
Cancer patients who participate in regular physical exercise programs show significant improvements in physical and mental health, including enhanced stamina, muscle strength, and pain management. The studies found that exercise has a positive effect on quality of life, including functional, psychological, and emotional well-being.
A Mayo Clinic study reveals that many heart patients continue to take chest pain medications after undergoing angioplasty, suggesting a need for alternative treatment options. The gamma knife procedure is shown to be effective in treating various brain disorders, offering an alternative to surgery.
A study by the University of Pittsburgh Cancer Institute found that interferon alfa 2b significantly depresses the activity of internal enzymes breaking down narcotics and antidepressants. This may lead to overdose in cancer patients receiving these medications with IFNa2b.
Researchers have identified specific immune responses in patients treated with high doses of interferon alfa 2b to prevent melanoma recurrence. High-dose IFNa2b modulated the expression of MHC Class II antigens and increased natural killer cell activity, which may lead to better patient selection and therapy options.
Researchers have demonstrated a faster and safer approach to cancer vaccine therapy, producing encouraging results in melanoma patients. The new method involves using circulating white blood cells and moderate doses of IL-12, showing promise for treating advanced melanoma.
Researchers found that a small peptide, IM862, showed significant anti-angiogenesis activity in a human clinical trial, resulting in major responses in 37% of patients. The peptide inhibits blood vessel formation and modulates the immune system, offering a potential treatment for Kaposi's Sarcoma with improved safety profiles.
A retrospective statistical analysis of patients with advanced breast cancer found no survival benefit from high dose chemotherapy and bone marrow transplant. The study analyzed data from over 1,300 patients treated in the 1980s and early 1990s.
Researchers at Thomas Jefferson University have found that radiation therapy helps patients with localized prostate cancer live longer. After examining the results of 1560 patients who received radiation therapy alone for prostate cancer, they discovered that those with high-risk disease benefited the most from higher doses of radiation.
A USC study suggests that radiation therapy is not necessary for DCIS patients with margin widths of 10mm or more, and may even be counterproductive due to side effects and costs. Patients with narrower margins may benefit from postoperative radiation therapy.
The 'Demystifying Cancer' program brings together medical professionals, researchers, and experts to provide accurate information about cancer. Participants will learn about current therapies, clinical trials, and how to navigate the Internet for reliable information.
The Ablatherm device has shown local disease control in approximately 80% of cases, with a complete response in 56% and partial response in 24%. The treatment is minimally invasive and can be repeated if necessary, but may have some adverse effects.
The US Department of Energy's Brookhaven National Laboratory is offering a new clinical trial for brain tumor patients, including those whose cancer is inoperable or has regrown. The trial aims to increase the radiation dose and expand eligibility requirements for glioblastoma multiforme patients.
Researchers at Memorial Sloan-Kettering Cancer Center have shown that arsenic effectively induces remission in patients with acute promyelocytic leukemia (APL), a potentially fatal type of cancer. Eleven out of 12 patients achieved remission after treatment with low doses of arsenic trioxide, experiencing mild side effects.
Researchers are developing a new alternative treatment for cancer using radio-frequency ablation, which heats diseased cells with a fine electrode. The technique has shown promising results in treating liver cancers, with nine out of twelve patients remaining cancer-free for more than a year.
A study found that high-risk prostate cancer patients treated with seed implant therapy had poorer outcomes compared to radical prostectomy and external beam radiation. The researchers suggest that high-risk patients should discuss alternative treatment options with their physicians.
Researchers aim to prevent leukemia relapse by educating the immune system using immunotherapy and genetically modified cells. The new technology could eliminate second rounds of chemotherapy, reducing toxicity and hospital stays.
A new study found that patients with tumors expressing low levels of the tumor suppressor protein p21 are more likely to recur and die from bladder cancer than those with elevated p21 levels. The study suggests that knowing both p53 and p21 status is a more powerful indicator of risk, allowing for clearer treatment decisions.
A rare medical archive enabled researchers to determine that patients with high nm23 levels and low density of newly formed blood vessels were more likely to survive 14 years after treatment. Low micro-vessel count was also a predictor, with 92% of patients surviving at least 14 years.
A new study by Duke University Medical Center found that a combination of intensive, twice-daily radiation therapy and simultaneous chemotherapy can control cancer more frequently. The treatment resulted in a significant improvement in disease control and patient survival rates.
A new study found that daily pain among elderly nursing home residents with cancer is widespread and often untreated, especially among older and minority patients. The study highlights inadequate medical treatment and a need for improving pain management in these individuals.
In a Phase II study combining ONYX-015 with standard chemotherapy, nine out of ten patients experienced tumor regressions greater than 50 percent, including two complete responses. Thirty percent of patients treated with ONYX-015 alone showed significant tumor regression.
A phase III clinical trial suggests that suramin offers substantial pain reduction and moderate delay in disease progression for patients with advanced prostate cancer. The study involved 458 patients, who experienced significant pain reduction and a longer period of time compared to those receiving only hydrocortisone and a placebo.
Researchers at Thomas Jefferson University have created an autologous ovarian cancer vaccine that stimulates an immune response in patients, showing promise for treatment. The vaccine is custom-made for each patient and has been safe with no significant side effects, paving the way for further clinical trials.
A study by Memorial Sloan-Kettering Cancer Center found that 77% of adult AML patients who received a T-cell depleted bone marrow transplant were cancer-free after 6 years. The treatment limits graft-versus-host disease risk and leukemic recurrence.
Researchers at Thomas Jefferson University are conducting a gene therapy trial for glioblastoma, a form of brain cancer. The trial aims to delay disease progression and improve quality of life for patients, offering a potential cure for the deadliest type of brain tumor.
Scientists at NIH developed a new drug that reduces tumor size without severe side effects. In a clinical trial, 9 of 15 patients had significant tumor regression, with complete disappearance in two cases. A related therapy using virus-producing cells also showed promise, but only for small tumors.
A US research team, led by Dr. Barton Kamen, has made significant progress in treating stubborn cancers with aminopterin, a drug that was previously shelved due to toxicity concerns. The FDA has granted $447,534 for further studies on the drug, which shows promise in treating patients with leukemia and other cancers.
A study by CWRU sociologists found that adults who identify as survivors earlier in their cancer journey tend to have better mental health outcomes. Adopting a survivor mindset can help individuals adopt an active role in the healing process and reduce distress.
A new study of over 1,000 prostate cancer patients found that those who underwent surgery had remarkably good outcomes, with few reporting dissatisfaction or problems with urinary or sexual function. Despite fears about complications, most men felt healthier and satisfied with their treatment after surgery.
Researchers at University at Buffalo and Roswell Park Cancer Institute found no link between chemotherapy use and cancer risk in children's offspring. The study analyzed health records of 153 children born to 91 chemotherapy patients, showing none developed cancer.
Researchers at Brown University have developed a drug and radiation regimen that demonstrates substantial activity in reducing locally advanced and inoperable tumors in the pancreas and stomach.
Hospice care is underused in the US, with most patients enrolling too late to benefit from it. Short stays can lessen the effectiveness of hospice care, leaving little time for caregivers to learn about the patient's needs and arrange optimal care.
A new clinical trial has shown that combining chemotherapy with radiation therapy can improve the survival rate of patients with nasopharyngeal carcinoma by 31% compared to radiation alone. The treatment, which included cisplatin and 5-fluorouracil, resulted in a three-year survival rate of 76% for those receiving the combination therapy.
A new drug, CPT-11, has been approved by the FDA for treating colorectal cancer. Researchers plan to enroll approximately 660 patients in a Phase III trial to evaluate its effectiveness as a first-line treatment.